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Skin from patients with inherited disorders of connec­
tive tissue metabolism (EDS Types I-IX, Marfan's syn­
drome, osteogenesis imperfecta, spondyloepiphyseal 
dysplasia, and cutis laxa) has been examined by light 
and transmission electron microscopy for defects in the 
collagen and elastic fibrous connective tissue which may 
explain the clinical disorder and/or correlate with the 
biochemical defect (where known). Alterations were ob­
served in the organization of the dermis and in the 
individual collagen and elastic fibers. The major altera­
tions observed among collagen fibrils were hieroglyphic­
shaped fibrils, collagen flowers, unravelled fibrils and 
fibrils of normal shape but abnormally large or small 
diameters or a mixed population of both. Elastic fibrils 
were sometimes fragmented, highly branched, granular, 
densely stained and had inclusions suggestive of cellular 
debris. These changes appeared to be a consequence of 
degradative processes. Other fibers were seen with a 
paucity of elastin matrix associated with the microfibrils 
or with totally separate deposition of the two elastic 
fiber components. Such fibers were barely visible by 
light microscopy. Alterations were observed in tissue 
concurrently regardless of whether the biochemical de­
fect was related to only one of these connective tissue 
structures. The observations support an hypothesis that 
alterations in one component of the connective tissue 
matrix may influence the deposition and structure of 
others, ultimately, modifying the overall organization 
and mechanical properties of the tissue. 
Histologic and ultrastructural studies of skin from patients 
with inherited connective tissue disorders have revealed alter­
ations in the architecture of the dermis and in the individual 
collagen and elastic fibrous elements. From our own coordi­
nated clinical, biochemical, and morphologic studies of skin 
from individuals affected with the Ehlers-Danlos syndromes 
(EDS Types I-IX), the Marfan syndrome, osteogenesis imper­
fecta (01, Types I and II), cutis laxa, spondyloepiphyseal dys­
plasia (SED), and pseudoxanthoma elasticum (PXE), it is be­
coming increasingly apparent that there are no structural alter­
ations in either collagen fibrils or elastic fibers which are 
uniquely specific for a given disease; instead, one or more 
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is 
patterns of alteration of the connective tissue matrix as a whole 
are predictable for a disease, and even then, these are nonspe­
cific. Moreover, there appears to be a limited repertoire of 
morphologic alterations and this affects (with few exceptions) 
only the reticular dermis. 
It is also difficult to assign a given morphologic change to a 
specific biochemical defect, for the same alterations in a fibril 
or fiber can occur in instances where there is no obvious 
similarity in the molecular defect. Thus, the changes we observe 
seem to indicate that the dermal connective tissue matrix elicits 
a coordinated response to a single gene change, i.e., an alteration 
in one structural protein, regardless of the level of alteration in 
the biosynthetic pathway, may influence not only that protein 
but also the deposition and structure of others, ultimately 
modifying the overall architecture and mechanical properties 
of the tissue. In this sense, then, the structural abnormalities 
bear a closer relationship with the clinical findings than with 
biochemical defect. 
This review is limited to a discussion of the alterations of 
collagen and elastic connective tissue as they occur in the skin, 
ignoring the fact that in some of the diseases (e.g., osteogenesis 
imperfecta, Marfan syndrome) the organ system primarily in­
volved is other than the skin. Most of the structural data are 
from our O\vn published or new (*) studies. These results are 
compared with or supplemented by recent findings of others, 
and, finally, discussed in the context of the biochemical altera­
tions(s) described for the disease. The data are not exhaustive 
but were selected to demonstrate the major patterns of change 
we have observed after surveying many patients affected with 
each disorder. From the summary charts, it is clear that even 
though patterns of change can be recognized, each disease 
exhibits substantial heterogeneity in both structural and bio­
chemical abnormalities. 
MATERIALS AND METHODS 
Skin biopsy specimens from patients with a variety of inherited 
connective tissue disorders were obtained from the extensor surface of 
upper the arm. They were immersed in 1/2 strength Karnovksy's 
fixative (1) buffered in 0.1 M cacodylate buffer and fixed for 2-4 hr in 
cold. Samples were washed in buffer, postfixed in 1% OSO, ill distilled 
water for an additional hour, soaked in 1% aqueous uranyl acetate for 
1 hr to stain en bloc, and dehydrated through a graded series of 
alcohols_ Samples for light microscopy and transmission electron mi­
croscopy were further dehydrated into propylene oxide and embedded 
in Epon by conventional methods [2]. For scanning electron microscopy 
samples were dehydrated through an alcohol-freon series into 1009" 
freon 113 (Genesolv) and critical point dried in the pressure chamber 
of a BOMAH critical point bomb using freon 13 as the transit ional fluid 
[21- Dried specimens were mounted on aluminum stubs, sputter coated 
with gold palladium alloy and viewed in an ETEC scanning electron 
microscopy at 20 kv accelerating voltage and in the secondary electron 
mode. Embedded specimens were prepared in 1 flm sections for light 
microscopy and 80 nm sections for TEM. Thick sections were stained 
by the method of Richardson [4], thin sections were stained with 17< 
phosphotungstic acid in water, saturated uranyl acetate, and with lead 
citrate [5] and viewed in a Philips 201 transmission electron microscope. 
RESULTS 
Alterations in tissue architecture and in individual collagen 
and elastic fibers are found in the skin from patients with 
88 HOLBROOK AND BYERS 
TABLE I. Structural alterations of collagen fibrils 
Structural 
alterations 
Hieroglyphic fi­
brils 
Collagen flow­
ers 
Disorder 
Dermatosparactic calves 
Dermatosparactic sheep 
Dermatosparactic cat 
Dermatosparactic dog 
Ehlers-Danlos Type I 
Ehlers- Danlos Type II 
Ehlers-Danlos Type III 
Ehlers- Danlos Type V 
Ehlers- Danlos Type VI 
Ehlers-Danlos Type VII 
Ehlers-Danlos Type IX 
Pseudoxanthoma elasti-
cum 
Reference to 
structural 
abnormality 
11, 12,  49, 50 
9, 10 
13 
(Holbrook KA, 
Counts DF, Byers 
PH, Hegreberg 
GA: Unpublished 
observation) 
18, 19, 20 
18 
18 , 20 
20 
18 
17 
21, 22' 
Elastosis perforans serpi- 23 
ginosa 
Osteogenesis imperfecta 36 
Type I 
Buschke-Ollendorff 25 
Cutis laxa 
Unravelled fi- SpondyloepiphyseaI dys-
brils plasia 
Ehlers-Danlos Type I 
Small diameter Ehlers-Danlos Type IV 
fibrils Marfan Syndrome 
Osteogenesis imperfecta 
Large diameter Ehlers-Danlos Type I 
fibrils Ehlers-Danlos Type II 
Ehlers- Danlos Type III 
Ehlers-Danlos Type IV 
Ehlers-Danlos Type VI 
X-linked cutis laxa 
Variable diame- Ehlers-Danlos Type II 
ters Ehlers-Danlos Type III 
Ehlers-Danlos Type IV 
Ehlers-Danlos Type VII 
Ehlers-Danlos Type VIII 
Cutis laxa 
24,* 
28 
18,31-55 
36 
17, 18 
18 
18,20 
35 
18 
29 
32,33,35 
37 
inherited disorders of connective tissue metabolism. The differ­
ent major alterations of each fiber type are described and 
related to the diseases in which they were observed (Table 1). 
In a subsequent section the simultaneous expression of collagen 
and elastic fiber alterations are summarized (Table II) and the 
patterns of connective tissue which may be identified with a 
syndrome are discussed in relation to the biochemical defects 
(where known) identified for the disorder. The reader is referred 
to a previous paper in this symposium [6] for histologic and 
ultrastructural details of the normal dermis. 
Alterations in Dermal Architecture 
Normal skin thickness is regionally variable [7], but in some 
disorders (e.g., EDS IV, some forms of the Marfan syndrome, 
cutis laxa) marked thinning of the dermis is a hallmark of the 
disease. This can reflect both a diminished quantity of collagen 
and a finer organization of collagen bundles. The overall con­
sequence is a dermis with "fine texture," which may lack the 
normal interweaving of fiber bundles, or with a laminated 
appearance. Laminar organization of the dermis is characteris­
tic of fetal dermis during late stages of development. Con­
versely, the dermis may become exaggerated in thickness and 
consist of unusually large, dense fiber bundles. In addition, the 
relationships of structurally normal or abnormal elastic fibers 
with collagen fiber bundles can be altered such that elastic 
fibers are embedded within bundles rather than peripheral to 
them. Other changes in collagen-elastic fiber bundle relation-
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ships can occur when one or both of the fibers is structurally 
abnormal. 
Unfortunately, there are no thorough studies of the range of 
individual variation in dermal organization among normal in­
dividuals of the same age and at different stages of life. Without 
these data, evaluation of dermal architecture must be per­
formed cautiously and correlated with other more specific 
changes in the matrix of connective tissue biochemistry which 
could account for an overall modification. 
Alterations in Collagen Fibrils 
One of the first alterations of collagen fibrils identified in skin 
was the so-called ribbon- or rope-like fibril observed in the 
dermis of sheep and cattle with dermatosparaxis [9-12]. In 
longitudinal section these fibrils appeared loosely wound and 
flat or helical (Fig 1) ; in cross section they had 3-4 irregular, 
thin, projecting arms which gave them the appearance of 
"hieroglyphics" (Fig 1). Similar fibrils have also been reported 
in the skin of dermatosparactic cats [13, 14] and observed in a 
dermatosparactic dog (Holbrook KA, Counts DF, Byers PH, 
Hegreberg GA: unpublished observations). Only 2 ultrastruc­
tural studies of skin from patients with the same disorder (EDS 
VII, arthrochalasis multiplex congenital have been reported. In 
the frrst instance, skin structure was normal and in the second, 
collagen flowers (see below) were observed [15-17]. 
Collagen flowers, wires, ropes, stars and aggregates have been 
used to describe another aberrant structure of the collagen fibril 
(Fig 2). The appearance of the fibrils in cross section (Fig 2a) 
suggests the flower nomenclature but in longitudinal section 
each fibril appears as a loose assembly of component filament 
bundles which form wide diameter, twisted ropes (Fig 2b). The 
normal 640 A banding pattern of collagen is preserved across 
all elements of these aggregated structures. Collagen flowers 
are among the most frequently observed deviations in fibril 
structure, a nonspecific alteration which has been observed in 
skin of patients with EDS Types I [18-20], II [18], III [18,20], 
V [20], VI [18], VII [17] and IX (*), Type I or (*), PXE [21-
22], elastosis perforans serpiginosa (EPS) [25], cutis laxa 
[24, *], and the Buschke-Ollendorff Syndrome [25]. They also 
appear in actinically damaged skin [28] and can be formed in 
vitro from solutions of collagen and proteoglycan monomer in 
which the latter component is presumed to slow the rate of 
fibril assembly [27]. The serrated fibril (Fig 3a) described by 
Sevenich [20] appears to be a minor deviation of normal struc­
ture in the direction of the collagen flower and the highly 
irregular, almost hieroglyphic, fibril observed in 2 infants with 
EDS I (*) may be a variation of the collagen flowers, restricted 
in size and showing a broader spectrum of shapes (Fig 3b). 
Collagen flowers usually account for a low percentage of the 
fibrils per fibril bundle. The remaining fibrils are usually normal 
in shape but abnormally large or small in diameter (see below). 
Unravelled collagen fibrils have been observed in the dermis 
of one patient with a form of SED [29] and in another with 
EDS type I (*). In the first, fiber bundles were observed in 
which each fibril showed regions of dissociation along its length 
or at the ends where the banding pattern was lost and the 
component fIlaments were visible (Fig 4a). The reticular dermis 
of the second patient showed a "corduroy" pattern and fibrils 
which were normal in structure, flower-like and flower-like but 
more unravelled (Fig 4b). 'Unravelled" may be an unfortunate 
descriptive term because it implies dissociation of a once­
formed structure while, in fact, it is more likely that normal 
assembly is blocked during fibrillogenesis. 
Collagen fibrils which are normal in shape can deviate mark­
edly in diameter from the normal range (Fig 5). In certain 
disorders all fibrils are uniformly larger (EDS I [17, 18]), II 
[18], III [18, 20], VI [18], x-linked cutis laxa [29]) or smaller 
than normal (EDS I and II [32], IV [20, 33-36], VI [35], Marfan's 
(*) , Type I 01 [3]). In other cases, fiber bundles contain a mixed 
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TABLE II . Patterns of concurrent alteration in collagen and elastic connective tissue 
Disease 
Ehlers-Danlos Type I 
Ehlers-Danlos Type II 
Ehlers-Danlos Type III 
Ehlers-Danlos Type IV 
Ehlers-Danlos Type V 
Ehlers-Danlos Type VI 
Ehlers-Danlos Type VII 
(Animals: derma to­
sparaxis) 
Ehlers-Danlos Type VIII 
Ehlers-Danlos Type IX 
Pseudoxanthoma elasti-
cum 
Marfan Syndrome 
Elastosis perforans serpi­
ginosa 
Buschke-Ollendorff 
(Adults) 
(Adults) 
(Infants) 
Cutis laxa (Dominant and 
Recessive 
forms) 
(X-linked) 
Collagen Alteration 
Larger diameter fibrils, collagen 
flowers, excess diffuse matrix 
Small fibrils, disorganized bun­
dles 
Elastic Alteration 
Fragmented or unaltered 
? 
Bizarre flowers, poorly integrated Excessive microfibrils 
bundles 
Large diameter fibrils, collagen 
flowers, serrated fibrils 
Variable fibril diameters, colla­
gen flowers 
Small diameter fibrils, small bun­
dles 
Large diameter fibrils, collagen 
flowers, serrated fibrils 
Variable diameter fibrils 
Small diameter fibrils, variable 
diameter fibrils, excessive dif­
fuse matrix 
Small diameters, collagen flow­
ers, serrated 
Large diameter fibrils, collagen 
flowers 
Small diameter fibrils 
Poor collagen bundle integration 
and small bundles, excessive 
diffuse matrix 
Fibrils irregularly shaped or vari­
able in diameter, collagen de­
generation 
Small bundles 
Hieroglyphic-shaped fibrils, dis­
organized bundles 
Variable diameter 
Large diameter, collagen flowers 
Diminished amount of collagen, 
collagen flowers or unaltered 
Fragmented, variably stained, ex­
cessive amount or unaltered 
Excessive amounts 
? 
Unllltered 
Unaltered 
Excessive amount, branched, 
fragmented, contains inclu­
SIons 
Fragmented or ? 
Electron dense elastin or unal­
tered 
? 
Irregular in distribution 
Small, irregular unevenly stained 
fibers or large and unaltered 
"moth-eaten" 
Excessive microfibrils 
Unaltered 
Unaltered 
Electron dense inclusions, rag­
ged, fragmented, granular, 
"moth-eaten" focal calcifica­
tion 
Dense, angular fibrils, dissociated "moth-eaten" 
bundles, excessive diffuse ma-
trix 
Small diameter fibrils, but also Fragmented 
associated with excessive dif-
fuse material 
Collagen flowers, collagen and 
elastic fibers intermingled 
Collagen flowers 
Collagen unaltered 
Variable diameter; collagen and 
elastic fibers intermingled 
Collagen flowers or unaltered 
Markedly diminished collagen, 
small fibril diameter 
Large diameter fibrils, dense 
packing, excessive diffuse ma­
trix 
Large, dense, branched, frag­
mented fibers, globular elastic, 
excessive micro fibrils 
Broad interlacing, branched, 
globular elastin associated 
with a paucity of micro fibrils 
Decreased amount of elastic, 
small "dust-like" fibers, elastin 
deficient 
Globular, deficient, reticular elas­
tin, excessive, tangled microfil­
aments 
Fiber orientation abnormal, glob­
ular elastin, excessive microfi­
brils, deficient elastin 
Fragmented 
Unaltered 
References 
18,20, * 
30 
18-20 
30 
18, 20 
20, 30 
18,* 
33 
64 
17,37 
65 
9-12, 13, (Holbrook 
KA, Counts DF, 
Byers PH, Hegre­
berg GA: unpub­
lished observa­
tions) 
21,22,47,66 
43,67,68 
23 
25 
57, 58, 69, 7 1, * 
24, * 
Holbrook KA, Pin­
nell SR: unpub­
lished observa­
tions, * 
29 
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FIG 1. Hieroglyphic-shaped collagen fibrils from the skin of a dog 
with dermatosparaxis (EDS Type VII) (x 19,000). 
population of fibrils which span a range beyond the limits of 
either the normal maximum and minimum diameters (EDS II 
(*), EDS III (*), EDS IV [32, 33,*], EDS VII [37], EDS VIII 
(*), cutis laxa (*)). Fibrils of large and small diameter have also 
been found in the dermis of patients with scleroderma [38-40], 
multicentric reticulohistiocytoma [41] , in the dermis of the 
tight-skinned mouse [42], after treatment with the lathryogens 
f3-aminopropionitrile (f3-APN) and penicillamine [43] or the 
steroids hydroxycortisone 17 -butyrate and fluocinolone aceto­
nide [46], and in the dermis undergoing wound repair. 
Alterations in Elastic Fibers 
Alterations in elastic fibers are commonly observed in tissue 
from patients with diseases which primarily affect the collagen 
fibrils and in those where the elastic fiber appears to be the 
major abnormality. It has been stated that diseases of collagen 
metabolism are more often related to abnormalities in the 
biosynthesis of collagen than diseases of the elastic connective 
tissue, the latter being mainly degradative in nature [45). Our 
morphologic studies suggest, instead, that alterations in elastin 
deposition (perhaps a consequence of abnormal synthesis and/ 
or secretion) are responsible for many of the elastic connective 
tissue abnormalities (particularly cutis laxa), hence these dis­
orders also may be disorders of connective tissue biosynthesis. 
Apparent degradative changes in elastic fibers are seen in the 
dermis more frequently when the disease is associated with a 
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FIG 2. Collagen flower from the skin of a patient with a dominant 
form of Ehlers-Danlos syndrome in cross section (a) and longitudinal 
section (b). Normally shaped fibrils surround the abnormal fibrils in 
each fiber bundle (a, reduced from x 88,000; b, x 21,000). 
defect in collagen. Pathologic changes in elastic fibers, com­
pared with those of collagen fibers, are more difficult to distin­
guish from age-related changes. Age and environmentally in­
duced degradative alterations have been sorted out from met­
abolically induced changes by Braverman and Fonferko [46). 
There is a remarkable lack of biochemical data, however, on 
the molecular abnormalities in connective tissue diseases which 
primarily affect elastic fibers. 
Categories of elastic fiber alterations are more difficult to 
define than for collagen because the elastic fiber is made up of 
elastin (matrix) and microfibrillar (scaffolding) components. 
Thus changes in the composite fiber structure need to be 
identified in association with, or independent of, alterations in 
one or both components. Deviations in the amount, distribution 
and morphology of elastic fibers, in relation to changes in 
collagen, for each of the diseases studied are summarized in 
Table II. 
Like collagen, elastic fibers in the dermis can be deficient or 
excessive in quantity, form large and small fibers, assume 
abnormal shapes and patterns, and distribute irregularly in the 
dermis, sometimes integrated within collagen fiber bundles (Fig 
6). In some cases, the presumed increase is only an apparent 
increase and attributable to a reduction in the normal amount 
of collagen. Large, highly branched, fragmented (Fig 7) and 
irregularly shaped fibers, sometimes organized into reticular 
networks, have been observed (Fig 8). These are often described 
as "moth-eaten." 
Aside from the overall changes in fiber structure, there are 
also specific alterations in either the microfibrils or the elastin, 
although the microfibrils appear to be unusually constant and 
stable; they are present in tissue even when elastin is deficient. 
The only obvious alterations of microfibrils are in quantity and 
organization. Some elastic fibers appear to have excessive num­
bers of microfibrils embedded within the matrix and at the 
surface; others of them, particularly those deficient in elastin, 
show tangled rather than linearly oriented microfibrils (Fig 9a). 
In some instances (e.g., cutix laxa, *), small or large amounts of 
unstained elastin (indicative of "mature" elastin) are deposited 
as disconnected globules (Fig 9b), a diffuse reticulum along the 
microfibrillar scaffolding (Fig 9c), or independent of the micro­
fibrils altogether (Fig 9a). The elastin matrix also may appear 
reticular or granular and stain darkly with cationic dyes (Fig 
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FIG 3. a, Serrated collagen fibrils from the skin of a patient with Ehlers-Danlos Type III. b, Severely abnormal collagen fibrils from an infant 
with Type I Ehlers-Danlos syndrome (a, x 57,000; b x 73,000). 
FIG 4. a, Unravelled collagen fibril from the skin of a patient with spondyloepiphyseal dysplasia. b, Unravelled collagen fibril in the skin of a 
patient with Ehlers-Danlos syndrome Type I (a, x 40,000; b, x 47,000). 
128 HOLBROOK AND BYERS 
FIG 5. Collagen fibrils with variable diameter and slight irregularity 
in shape found in the skin of a patient with Ehlers-Danlos syndrome 
Type IV (x 42,(00). 
FIG 6. Abnormal elastic fibers integrated into a bundle of collagen 
fibrils found in dermis of patients with cutis laxa (reduced from X 
15,(00). 
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FIG 7. Network of elastic fibers (E) that are abnormal in structure 
and excessive in quality found in the dermis of a patient with Ehlers­
Danlos syndrome Type IV (x 4,(00). 
lOa). In tissue from patients with PXE, calcium deposits may 
accumulate within the matrix [21-47] (Fig lOb). 
Alterations in the Ground Substance 
Although the proteoglycans (PGs) and glycosaminoglycans 
(GAGs) have a well recognized role in influencing assembly of 
the fibrous matrix proteins [48], we have made no attempt to 
review structural changes in these components. To do so would 
have required special processing of tissue to preserve and iden­
tify these diffusely organized molecules. However, in Table II 
and in the following section we will point out instances where 
excessive accumulations of diffuse matrix molecules were ob­
served and discuss overall patterns of matrix changes in consid­
eration of the biochemistry of these molecules. 
Concurrent Alterations in Collagenous and Elastic Fibers 
and Biochemical Consideration 
We have described changes in the dermal architecture, alter­
ations in the specific fibrillar components and have illustrated 
the nonspecificity of these alterations for a single disease or 
biochemical defect. The alterations of collagen and elastic con­
nective tissue have been described as separate entities whereas 
in the majority of instances they occur concurrently (Table 11), 
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consistent with our original contention that alterations in one 
component of the connective tissue influence the matrix as a 
whole. From the data summarized in Table II it is impossible 
to synthesize a pattern of structural change that describes the 
dermis of patients with certain inherited connective tissue 
disorders. For some of these disorders a biochemical defect also 
has been identified. 
The dermis of the dermatosparactic animals shows one of the 
more consistent patterns of alteration. It is thin, finely textured, 
has small fiber bundles and hieroglyphic fibrils. The altered 
fibrils in affected animals are believed to be the result of 
abnormal packing of collagen molecules which retain the amino 
terminal extension peptides, a consequence of a defect in an 
amino terminal pro collagen peptidase enzyme [49-51]' A 
"dermal morphology" cannot be described from data on only 
two patients although neither appeared to have the same al­
tered fibril structure even though the consequence (retention 
of amino terminal propeptides) of the biochemical defect on the 
procollagen molecules in both individuals was the same. In one 
patient the enzyme (as in animals) was deficient [15]; in the 
other, a defect in a portion of the 0:2 chain of type I pro collagen 
prevented normal cleavage by the pro collagen peptidase en­
zyme [16]. 
The dermis from patients with the dominantly inherited 
forms of EDS (Types I-III) is usually of normal thickness but 
varies in density. In all individuals we have examined, the fibrils 
were normal or large in diameter and collagen flowers were 
present. Only one report [30] presents the opposite observation 
of small diameter fibrils in skin from patients with types I and 
II. It is possible that those measurements were made from 
fibrils at a different level of the dermis. Elastic fibrils have 
excessive microfibrils, are fragmented or are normal. The major 
alterations were seen in the collagen. 
There is only one account of a biochemical defect in tissue 
FIG 8. Fragmented appearing elastic fibers found in the dermis of a 
patient with Type I osteogenesis imperfecta (x 14,0(0). 
FIG 9. Abnormal structure of elastic fibers identified in the dermis 
of different patients with dominant and recessive forms of cutis laxa. a, 
microfibrils appear to be tangled and to lack normal amounts of elastin 
matrix. b, Small globular deposits of elastin are associated with bundles 
of micro fibrils. c, Deposition of an abnormally small amount of elastin 
on the microfibrils gives a reticular appearing pattern of elastic fibers 
structure. d, The elastin matrix appears to be deposited independent of 
the microfibrils (a, x 18,000; b, x 25,000; c, x 12,000; d, x 10,5(0). 
from patients with any of the dominant forms of EDS. Shinkai 
et al [52] reported an alteration in the ratio of PGs:GAGs 
secreted by cultured fibroblasts obtained from a patient with 
EDS I and inhibition of the conversion of pro collagen to colla­
gen. Unfortunately, morphological studies were not carried out 
in conjunction with the biochemical studies, thus we do not 
know if this patient expressed the structural alterations that fit 
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our pattern. The influence of proteoglycan on both collagen 
and elastin fibril formation is well recognized [47, 53]. 
Patients with EDS Type IV can be expected to have a thin 
dermis, usually deficient in collagen, fine organization of small 
fiber bundles and a real or apparent increase in elastic connec­
tive tissue. Collagen fibrils are usually small in diameter or 
occur in a dual population based on diameter. Elastic fibers are 
reticular, branched, fragmented and contain debris-like inclu­
sions. Pools of diffuse material accumulate in the tissue. 
EDS IV is a disorder of Type III collagen metabolism [54, 
55]. How this relates to the morphology, however, is totally 
speculative. Type III collagen comprises only 10-15% of dermal 
collagen normally and much of this is localized in the papillary 
dermis, surrounding vessels and in appendage sheathes. Type 
III fibrils are "thin fibrils" [56], yet these individuals who lack 
type III have thin fibrils as the dominant population or as one 
group of a mixed population. It is interesting that collagen 
flowers are not seen in patients of type IV EDS. 
Inherited (recessive or dominant) cutis laxa can be recognized 
at the light microscopic level by the small amount of stainable 
elastic fibers in the reticular dermis and by the small collagen 
fiber bundles. The elastic fibers appear as specks rather than 
bands. In nearly every case we have examined, the elastin 
matrix is deficient and the microfibrils appear excessive and 
intermixed with collagen. Collagen fibrils are often variable in 
diameter. Serum elastase inhibition associated with low serum 
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copper was an inconsistent finding among patients with cutis 
laxa [57, 58]. Diminished collagen production is believed to 
account for the clinical presentation in another patient with 
cutis laxa (Holbrook KA, Pinnell SR: unpublished observa­
tions). The cutis laxa-like morphology is also seen in skin after 
treatment with penicillamine and ,B-APN, lathryogenic com­
pounds which prevent normal crosslin king by noncompetitive 
inhibition of the enzyme lysyl oxidase [59]. In only the X-linked 
form of cutis laxa, however, has decreased lysyl oxidase activity 
been identified [29] and tissue from this patient appears to be 
an exception to the morphologic changes in cutis laxa: collagen 
fibrils are unusually large, fiber bundles are dense and elastic 
fibrils are normal. 
For the other diseases in which structural abnormalities have 
been recognized, we have not yet examined tissue from an 
adequate number of patients to permit description of an abnor­
mal pattern, but for many of them a biochemical defect has 
been recognized, hence the structural alterations can be pre­
sented in light of these data. In addition to type I EDS, collagen 
flowers can form in conditions where there is a molecular defect 
in one of the collagen chains (EDS VII; [16]), in enzymes which 
affect posttranslational modification (lysyl oxidase, EDS V 
([60], biochemical data in question, [61]); prolyl hydroxylse, 
EDS VI [62] and EPS [23], where secretion of (1'1 (I) chains are 
50% the normal amount (0.1. type I, [35]), when the amount of 
elastin is elevated several fold (Buschke-Ollendorff, [25], and in 
July 1982 STRUCTURAL ALTERATIONS IN CONNECTIVE TISSUE DISEASES 15s 
..,.. 
10a 
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instances where there is a defect in fibronectin as indicated by 
defective platelet attachment to collagen (EDS IX, [63]), These 
abnormal structures account for only a small percentage of the 
fibrils; the majority of the fibrils in skin of these patients may 
be normal in shape but abnormally large (EDS III) or small (I, 
II, VI, Type I 01) in diameter. The conditions under which 
fibrils of a wide range of diameters occur simultaneously are 
also varied. The biochemical alterations in EDS, I, II, IV, and 
VII have been described previously. They are not known for 
EDS VIn or cutis laxa. What this deviation means in terms of 
tissue pathology is confusing in view of finding the same di­
ameter variability in normal papillary dermis of some individ­
uals and in tendon and fascia. 
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